Article ; Online: Efficacy and safety profiles of manidipine compared with amlodipine: a meta-analysis of head-to-head trials.
2010 Volume 20, Issue 1, Page(s) 54–59
Abstract: Abstract The aim of this meta-analysis was to compare the efficacy and safety profile of manidipine ... efficacy/safety ratio of manidipine over amlodipine. ... patients (436 received manidipine and 402 received amlodipine) were included. The efficacy of manidipine ...
| Abstract | Abstract The aim of this meta-analysis was to compare the efficacy and safety profile of manidipine 20 mg with that of amlodipine 10 mg. A systematic research of quantitative data produced or published between 1995 and 2009 was performed. Head-to-head randomized controlled trials (RCTs) of 12 months minimum duration reporting comparative efficacy (changes in systolic and diastolic blood pressure) and safety (total adverse events and ankle oedema), were included. Four high-quality RCTs, accounting for 838 patients (436 received manidipine and 402 received amlodipine) were included. The efficacy of manidipine and amlodipine was statistically equivalent: effect size for DBP = -0.08 (p = 0.22) and SBP = -0.01 (p = 0.83). The global safety of manidipine was significantly better than amlodipine: the relative risk (RR) for adverse event was 0.69 (0.56-0.85), and particularly for ankle oedema RR was 0.35 (0.22-0.54). Publication bias was not significant and the robustness of the analyses was good. These data suggest a better efficacy/safety ratio of manidipine over amlodipine. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Adult ; Amlodipine/adverse effects ; Amlodipine/pharmacology ; Amlodipine/therapeutic use ; Ankle ; Antihypertensive Agents/adverse effects ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Blood Pressure/drug effects ; Dihydropyridines/adverse effects ; Dihydropyridines/pharmacology ; Dihydropyridines/therapeutic use ; Edema/complications ; Humans ; Hypertension/drug therapy ; Hypertension/physiopathology ; Meta-Analysis as Topic ; Nitrobenzenes ; Piperazines ; Publication Bias ; Randomized Controlled Trials as Topic ; Treatment Outcome | |||||
| Chemical Substances | Antihypertensive Agents ; Dihydropyridines ; Nitrobenzenes ; Piperazines ; Amlodipine (1J444QC288) ; manidipine (6O4754US88) | |||||
| Language | English | |||||
| Publishing date | 2010-10-14 | |||||
| Publishing country | England | |||||
| Document type | Comparative Study ; Journal Article ; Meta-Analysis | |||||
| ZDB-ID | 1170048-8 | |||||
| ISSN | 1651-1999 ; 1651-2480 ; 0803-7051 ; 0803-8023 | |||||
| ISSN (online) | 1651-1999 ; 1651-2480 | |||||
| ISSN | 0803-7051 ; 0803-8023 | |||||
| DOI | 10.3109/08037051.2010.518670 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 3843: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.